المؤلفون: Sun Z; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Division of Biostatistics, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address: zhuoxin@jimmy.harvard.edu., Niman SM; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Division of Biostatistics, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address: sniman@jimmy.harvard.edu., Pagani O; Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. Electronic address: opagani@bluewin.ch., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Electronic address: ahpartridge@partners.org., Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, Av. Batallon de San Patricio 112, 66278, San Pedro Garza Garcia, Mexico. Electronic address: hatem.azim@gmail.com., Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Program, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy. Electronic address: fedro.peccatori@ieo.it., Ruggeri M; International Breast Cancer Study Group, Program for Young Patients, Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. Electronic address: monica.ruggeri@ibcsg.org., Di Leo A; 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Prato, 59100, Italy. Electronic address: angelo.dileo@uslcentro.toscana.it., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: marco.colleoni@ieo.it., Gelber RD; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, And Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address: gelber@jimmy.harvard.edu., Regan MM; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address: mregan@jimmy.harvard.edu.

مؤلفون مشاركون: POSITIVE Steering Committee

المصدر: Breast (Edinburgh, Scotland) [Breast] 2020 Oct; Vol. 53, pp. 1-7. Date of Electronic Publication: 2020 Jun 02.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*administration & dosage , Breast Neoplasms/*drug therapy , Chemotherapy, Adjuvant/*methods , Historically Controlled Study/*methods , Non-Randomized Controlled Trials as Topic/*methods, Adolescent ; Adult ; Breast Neoplasms/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; Non-Randomized Controlled Trials as Topic/ethics ; Pregnancy ; Proportional Hazards Models ; Prospective Studies ; Randomized Controlled Trials as Topic/ethics ; Receptor, ErbB-2/metabolism ; Withholding Treatment ; Young Adult

المؤلفون: Pistilli B; Institut Gustave Roussy, Villejuif, France., Paci A; Institut Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Faculté de Pharmacie, Saint-Aubin, France., Ferreira AR; Institut Gustave Roussy, Villejuif, France.; INSERM-Unit 981, Villejuif, France.; Fundacao Champalimaud, Lisbon, Portugal., Di Meglio A; Institut Gustave Roussy, Villejuif, France.; INSERM-Unit 981, Villejuif, France., Poinsignon V; Institut Gustave Roussy, Villejuif, France., Bardet A; Institut Gustave Roussy, Villejuif, France.; INSERM-Unit 1018, Villejuif, France., Menvielle G; Institut Pierre Louis d'Epidemiologie et de Santé Publique, Paris, France., Dumas A; INSERM-Unit 1018, Villejuif, France.; UMR-Unit 1123, Paris, France.; Université Paris Diderot UFR de Médecine, Paris, France., Pinto S; Institut Pierre Louis d'Epidemiologie et de Santé Publique, Paris, France., Dauchy S; Institut Gustave Roussy, Villejuif, France., Fasse L; Institut Gustave Roussy, Villejuif, France.; Université Paris Decartes, Paris, France., Cottu PH; Institut Curie, Paris, France., Lerebours F; Institut Curie, Paris, France., Coutant C; Georges-Francois Leclerc Centre, Dijon, France., Lesur A; Institut de Cancerologie de Lorraine, Nancy, France., Tredan O; Centre Léon Bérard, Lyon, France., Soulie P; Institut de Cancerologie de L'Ouest, Saint Herblain, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Jouannaud C; Institut Jean Godinot, Reims, France., Levy C; Centre Francois Baclesse Centre Lutte Contre le Cancer, Caen, France., Everhard S; UNICANCER, Paris, France., Arveux P; INSERM-Unit 1018, Villejuif, France.; Georges-Francois Leclerc Centre, Dijon, France., Martin AL; UNICANCER, Paris, France., Dima A; Université Claude Bernard, Villeurbanne, France., Lin NU; Dana-Farber Cancer Institute, Boston, MA., Partridge AH; Dana-Farber Cancer Institute, Boston, MA., Delaloge S; Institut Gustave Roussy, Villejuif, France., Michiels S; Institut Gustave Roussy, Villejuif, France.; INSERM-Unit 1018, Villejuif, France., André F; Institut Gustave Roussy, Villejuif, France.; INSERM-Unit 981, Villejuif, France., Vaz-Luis I; Institut Gustave Roussy, Villejuif, France.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Aug 20; Vol. 38 (24), pp. 2762-2772. Date of Electronic Publication: 2020 Jun 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*blood , Antineoplastic Agents, Hormonal/*therapeutic use , Breast Neoplasms/*drug therapy , Chemotherapy, Adjuvant/*methods , Medication Adherence/*statistics & numerical data , Tamoxifen/*blood , Tamoxifen/*therapeutic use, Adult ; Antineoplastic Agents, Hormonal/pharmacology ; Female ; Humans ; Middle Aged ; Prospective Studies ; Tamoxifen/pharmacology ; Treatment Outcome

المؤلفون: Gajra A; SUNY Upstate Medical University, Syracuse, NY, United States. Electronic address: gajraa@upstate.edu., McCall L; Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, United States., Muss HB; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, United States., Cohen HJ; Duke University Medical Center, Durham, NC, United States., Jatoi A; Mayo Clinic, Rochester, MN, United States., Ballman KV; Mayo Clinic, Rochester, MN, United States; Weill Medical College of Cornell University, New York, NY, United States., Partridge AH; Dana-Farber/Partners CancerCare, Boston, MA, United States., Sutton L; Duke University Medical Center, Durham, NC, United States., Parker BA; UC San Diego Moores Cancer Center, La Jolla, CA, United States., Magrinat G; Cone Health Cancer Center, Greensboro, NC, United States., Klepin HD; Wake Forest University Health Sciences, Winston-Salem, NC, United States., Lafky JM; Mayo Clinic, Rochester, MN, United States., Hurria A; City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2018 May; Vol. 9 (3), pp. 221-227. Date of Electronic Publication: 2018 Mar 28.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol

مواضيع طبية MeSH: Patient Preference*, Breast Neoplasms/*psychology , Chemotherapy, Adjuvant/*psychology , Quality of Life/*psychology, Age Factors ; Aged ; Breast Neoplasms/drug therapy ; Chemotherapy, Adjuvant/adverse effects ; Decision Making ; Female ; Humans ; Nausea/chemically induced ; Surveys and Questionnaires ; Treatment Refusal/psychology ; Vomiting/chemically induced

المؤلفون: Vaz-Luis I; Dana-Farber Cancer Institute, Boston, Massachusetts., O'Neill A; Dana-Farber Cancer Institute, Boston, Massachusetts., Sepucha K; Massachusetts General Hospital, Boston, Massachusetts., Miller KD; Indiana University Simon Cancer Center, Indianapolis, Indiana., Baker E; Dana-Farber Cancer Institute, Boston, Massachusetts., Dang CT; Memorial Sloan Kettering Cancer Center, New York, New York., Northfelt DW; Mayo Clinic, Scottsdale, Arizona., Winer EP; Dana-Farber Cancer Institute, Boston, Massachusetts., Sledge GW; Indiana University Simon Cancer Center, Indianapolis, Indiana., Schneider B; Indiana University Simon Cancer Center, Indianapolis, Indiana., Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts.

المصدر: Cancer [Cancer] 2017 Aug 01; Vol. 123 (15), pp. 2821-2828. Date of Electronic Publication: 2017 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Attitude of Health Personnel* , Attitude to Health* , Chemotherapy, Adjuvant* , Patient Preference* , Physicians* , Quality of Life*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy, Adult ; Aged ; Bevacizumab/administration & dosage ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Clinical Trials, Phase III as Topic ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Humans ; Mastectomy ; Mastectomy, Segmental ; Middle Aged ; Paclitaxel/administration & dosage ; Randomized Controlled Trials as Topic ; Risk Assessment ; Surveys and Questionnaires ; Survival Rate ; Tumor Burden

المؤلفون: Rosenberg SM; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA; Jonsson Comprehensive Cancer Center and Departments of Psychology and Psychiatry/Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA; Department of Psychological Medicine, University of Auckland, Auckland, New Zealand., Stanton AL; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA; Jonsson Comprehensive Cancer Center and Departments of Psychology and Psychiatry/Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA; Department of Psychological Medicine, University of Auckland, Auckland, New Zealand., Petrie KJ; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA; Jonsson Comprehensive Cancer Center and Departments of Psychology and Psychiatry/Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA; Department of Psychological Medicine, University of Auckland, Auckland, New Zealand., Partridge AH; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA; Jonsson Comprehensive Cancer Center and Departments of Psychology and Psychiatry/Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA; Department of Psychological Medicine, University of Auckland, Auckland, New Zealand ahpartridge@partners.org.

المصدر: The oncologist [Oncologist] 2015 Jun; Vol. 20 (6), pp. 598-604. Date of Electronic Publication: 2015 May 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Chemotherapy, Adjuvant/*adverse effects , Drug-Related Side Effects and Adverse Reactions/*pathology , Hormones/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/complications ; Breast Neoplasms/drug therapy ; Breast Neoplasms/psychology ; Combined Modality Therapy/adverse effects ; Drug-Related Side Effects and Adverse Reactions/psychology ; Female ; Hormones/adverse effects ; Humans ; Middle Aged ; Survivors/psychology ; Tamoxifen/administration & dosage ; Tamoxifen/adverse effects

المؤلفون: Partridge AH, Winer EP

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Jul 01; Vol. 23 (19), pp. 4259-61. Date of Electronic Publication: 2005 Apr 11.

نوع المنشور: Comment; Editorial

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*physiopathology , Chemotherapy, Adjuvant/*adverse effects , Fertility/*drug effects, Breast Neoplasms/therapy ; Female ; Fertility Agents/adverse effects ; Humans ; Ovulation Induction/adverse effects ; Premenopause ; Risk Assessment

المؤلفون: Partridge AH; Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. ahpartridge@partners.org, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Oct 15; Vol. 22 (20), pp. 4174-83.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Attitude to Health* , Chemotherapy, Adjuvant* , Fertility*, Breast Neoplasms/*psychology , Breast Neoplasms/*therapy, Adult ; Female ; Humans ; Logistic Models ; Menopause ; Risk

المؤلفون: Andrea Gombos, Audrey Mailliez, Ellen Warner, Janice M. Walshe, Christobel Saunders, Manuel Ruiz Borrego, Monica Ruggeri, Karen L. Smith, Aron Goldhirsch, Larissa A. Korde, Jeong Eon Lee, Virginia F. Borges, Judith R. Kroep, Christine Rousset-Jablonski, Anna Barbro Sætersdal, Vesna Bjelic-Radisic, Hatem A. Azim, Fedro A. Peccatori, Samuel M. Niman, Junko Takei, Olivia Pagani, Akemi Kataoka, Richard D. Gelber, Ann H. Partridge, Fatima Cardoso, Cristina Saura, Marco Colleoni, Martine Piccart, Simona Borštnar, Halle C. F. Moore, Snezana Susnjar, Frédéric Amant, Chikako Shimizu

المساهمون: Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, ARD - Amsterdam Reproduction and Development, Institut Català de la Salut, [Partridge AH] Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. [Niman SM] International Breast Cancer Study Group Statistical Center, Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. [Ruggeri M] International Breast Cancer Study Group, Program for Young Patients, Coordinating Center, Bern, 3008, Switzerland. [Peccatori FA] Fertility and Procreation Unit, Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, 20141, Italy. [Azim HA] Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, 66278, Mexico. [Colleoni M] International Breast Cancer Study Group, Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy. [Saura C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Breast (Edinburgh, Scotland), 59, 327-338. Churchill Livingstone
Scientia
Breast, Vol 59, Iss, Pp 327-338 (2021)
Breast, 59
The Breast : Official Journal of the European Society of Mastology

مصطلحات موضوعية: personas::sobrevivientes::supervivientes de cáncer [DENOMINACIONES DE GRUPOS], medicine.medical_treatment, Embaràs, Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::Pregnancy [PHENOMENA AND PROCESSES], Breastfeeding, THERAPY, fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazo [FENÓMENOS Y PROCESOS], Breast cancer, Mama - Càncer, Cancer Survivors, DE-ESCALATION, Pregnancy, Breast-conserving surgery, ASSAY, Fertility preservation, Other subheadings::/therapeutic use [Other subheadings], hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas [COMPUESTOS QUÍMICOS Y DROGAS], TREATMENT DECISIONS, RC254-282, Mastectomy, media_common, ISSUES, Persons::Survivors::Cancer Survivors [NAMED GROUPS], Obstetrics, Obstetrics & Gynecology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones [CHEMICALS AND DRUGS], Oncology, Chemotherapy, Adjuvant, Original Article, Female, Pregnancy desire, Life Sciences & Biomedicine, medicine.drug, Endocrine therapy, Adult, medicine.medical_specialty, Antineoplastic Agents, Hormonal, media_common.quotation_subject, Fertility, Breast Neoplasms, Treatment interruption, medicine, FERTILITY, Humans, ATTITUDES, Chirurgie, Science & Technology, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], Premenopausal women, medicine.disease, Hormones, Tamoxifen, Premenopause, Surgery, Young women, business, Hormonoteràpia

وصف الملف: application/pdf; Print-Electronic; 1 full-text file(s): application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc876445c4777ff2d7ed8a211ab65a48
https://hdl.handle.net/10668/18376